Recombinant CD37 (Naratuximab Biosimilar) 抗体
This anti-CD37 (Naratuximab Biosimilar) antibody is a 小鼠 Chimeric antibody detecting CD37 (Naratuximab Biosimilar) in FACS. Suitable for 人.
Quick Overview for Recombinant CD37 (Naratuximab Biosimilar) 抗体 (ABIN7093065)
抗原
CD37 (Naratuximab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
小鼠
克隆类型
Chimeric
标记
This CD37 (Naratuximab Biosimilar) antibody is un-conjugated
应用范围
Flow Cytometry (FACS)
质量等级
Research Grade
-
-
原理
- Anti-CD37 (naratuximab biosimilar) mAb
-
产品特性
- IMGN-529, IMGN529, K7153A-SMCC-DM1
-
纯化方法
- Purified from cell culture supernatant by affinity chromatography
-
亚型
- IgG1
-
-
-
-
应用备注
- Flow Cyt 1:100
-
说明
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Reconstitute with deionized water
-
缓冲液
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
储存条件
- -20 °C,-80 °C
-
储存方法
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
有效期
- 12 months
-
-
- CD37 (Naratuximab Biosimilar)
-
物质类
- Biosimilar
-
背景
- Synonyms: CD37, TSPAN26, Tspan-26
-
基因ID
- 951
-
UniProt
- P11049
抗原
-
You are here:
